A bill to prohibit the use of patient databases for marketing without the express consent of the patient.
Defines "individually identifiable health information" as certain information created by or received from a health care provider or other named entities that relates to the physical or mental health of an individual, the provision of health care to the individual, or payment by the individual for health services and that identifies the individual or reasonably can be used to identify the individual. Defines "marketing."
Permits health care providers, employers, and other named entities to provide marketing services to a pharmaceutical company if: (1) clear notice is given to individuals regarding disclosure practices for individually identifiable health information; and (2) written consent from the individual involved is obtained applying to a specific marketing purpose.
Introduced in Senate
Sponsor introductory remarks on measure. (CR S10046-10047)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S10047)
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line